• Something wrong with this record ?

Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade

Y. Mytsyk, I. Dutka, Y. Borys, I. Komnatska, I. Shatynska-Mytsyk, AA. Farooqi, K. Gazdikova, M. Caprnda, L. Rodrigo, P. Kruzliak,

. 2017 ; 49 (2) : 215-224. [pub] 20161116

Language English Country Netherlands

Document type Journal Article

E-resources Online Full text

NLK ProQuest Central from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-03-01 to 1 year ago
Health & Medicine (ProQuest) from 1999-01-01 to 1 year ago

BACKGROUND: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC. METHODS: The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC. RESULTS: There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10(-3) mm(2)/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11-Fuhrman grade I, 1.84 ± 0.14-Fuhrman grade II, 1.79 ± 0.10-Fuhrman grade III, 1.72 ± 0.06-Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB. CONCLUSION: The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031288
003      
CZ-PrNML
005      
20171030131943.0
007      
ta
008      
171025s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11255-016-1460-3 $2 doi
035    __
$a (PubMed)27853915
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mytsyk, Yulian $u Department of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine. mytsyk.yulian@i.ua.
245    10
$a Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade / $c Y. Mytsyk, I. Dutka, Y. Borys, I. Komnatska, I. Shatynska-Mytsyk, AA. Farooqi, K. Gazdikova, M. Caprnda, L. Rodrigo, P. Kruzliak,
520    9_
$a BACKGROUND: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC. METHODS: The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC. RESULTS: There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10(-3) mm(2)/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11-Fuhrman grade I, 1.84 ± 0.14-Fuhrman grade II, 1.79 ± 0.10-Fuhrman grade III, 1.72 ± 0.06-Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB. CONCLUSION: The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a karcinom z renálních buněk $x diagnóza $x patologie $7 D002292
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a difuzní magnetická rezonance $x metody $7 D038524
650    _2
$a přesnost dimenzionálního měření $7 D061827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a ledviny $x diagnostické zobrazování $x patologie $7 D007668
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a stupeň nádoru $7 D060787
650    _2
$a staging nádorů $7 D009367
650    _2
$a výběr pacientů $7 D018579
650    _2
$a prognóza $7 D011379
650    _2
$a zlepšení kvality $7 D058996
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dutka, Ihor $u Euroclinic Medical Center, Lviv, Ukraine.
700    1_
$a Borys, Yuriy $u Department of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine.
700    1_
$a Komnatska, Iryna $u Euroclinic Medical Center, Lviv, Ukraine.
700    1_
$a Shatynska-Mytsyk, Iryna $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
700    1_
$a Farooqi, Ammad Ahmad $u Laboratory of Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
700    1_
$a Gazdikova, Katarina $u Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Limbova 12, 833 03, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk. Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk.
700    1_
$a Caprnda, Martin $u University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
700    1_
$a Rodrigo, Luis $u University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
700    1_
$a Kruzliak, Peter $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1946/1, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com. 2nd Department of Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com.
773    0_
$w MED00002396 $t International urology and nephrology $x 1573-2584 $g Roč. 49, č. 2 (2017), s. 215-224
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27853915 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171030132032 $b ABA008
999    __
$a ok $b bmc $g 1254881 $s 992315
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 49 $c 2 $d 215-224 $e 20161116 $i 1573-2584 $m International urology and nephrology $n Int Urol Nephrol $x MED00002396
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...